Balance Sheet Details (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
|---|
| Balance Sheet Details [Abstract] |
|
| Schedule of Inventories |
Inventories, which primarily relate to Proclarix
product as of March 31, 2025 and Proclarix products as of December 31, 2024, consisted of the following:
| | |
March 31,
2025 | | |
December 31,
2024 | |
| Raw materials | |
$ | 91,174 | | |
$ | 57,446 | |
| Finished goods | |
| 64,486 | | |
| 6,633 | |
| Total | |
$ | 155,660 | | |
$ | 64,079 | |
|
| Schedule of Prepaid Expenses and Other Current Assets |
Prepaid expenses and other current assets consisted of the following
as of March 31, 2025, and December 31, 2024:
| | |
March 31,
2025 | | |
December 31,
2024 | |
| Prepaid insurance | |
$ | 617,362 | | |
$ | 101,999 | |
| Prepaid professional fees | |
| — | | |
| 7,487 | |
| VAT taxes receivable | |
| 40,309 | | |
| 28,756 | |
| Prepaid other | |
| 2,715 | | |
| 33,894 | |
| Other receivable | |
| 11,057 | | |
| 41,835 | |
| Total | |
$ | 671,443 | | |
$ | 213,971 | |
|
| Schedule of Goodwill |
Goodwill consisted of the following as of March
31, 2025 and December 31, 2024:
| Balance as of December 31, 2024 | |
$ | 27,048,973 | |
| Impairment loss | |
| (10,918,000 | ) |
| Foreign currency translation | |
| 78,536 | |
| Balance as of March 31, 2025 | |
$ | 16,209,509 | |
|
| Schedule of Accrued Expenses |
Accrued expenses consisted of the following as of March 31, 2025 and
December 31, 2024:
| | |
March 31,
2025 | | |
December 31,
2024 | |
| Accrued compensation | |
$ | 245,716 | | |
$ | 186,956 | |
| Accrued research and development | |
| 215,599 | | |
| 320,096 | |
| Accrued professional fees | |
| 209,618 | | |
| 161,981 | |
| Other accrued expenses | |
| 139,082 | | |
| 25,841 | |
| Accrued franchise taxes | |
| 80,000 | | |
| 40,000 | |
| Accrued interest | |
| 268,090 | | |
| 139,409 | |
| Accrued license fees | |
| 1,659 | | |
| 14,705 | |
| Total | |
$ | 1,159,764 | | |
$ | 888,988 | |
|